Cargando…
N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology
Increasing lines of evidence suggest a key role of oxidative stress in neurodegenerative diseases. Alzheimer’s disease, Parkinson’s disease, myoclonus epilepsy of the Unverricht-Lundborg type, spinocerebellar degeneration, tardive dyskinesia and Down’s syndrome have been associated with several mito...
Autores principales: | Arakawa, Motoki, Ito, Yoshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102236/ https://www.ncbi.nlm.nih.gov/pubmed/17853088 http://dx.doi.org/10.1080/14734220601142878 |
Ejemplares similares
-
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
por: Tardiolo, Giuseppe, et al.
Publicado: (2018) -
Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
por: Santus, Pierachille, et al.
Publicado: (2014) -
N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
por: Sahasrabudhe, Siddhee A., et al.
Publicado: (2023) -
Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015) -
Comparison between theophylline, N-acetylcysteine, and theophylline plus
N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Arabmomeni, Morteza, et al.
Publicado: (2015)